ADAM8 and Miyoshi myopathy: Since high-risk cytogenetic abnormalities are associated with shorter patient survival and e.g. the incidence of 1q amplifications/gains increases with MM progression [44–47], the role of ADAM8/9/15 in the prognosis and progression of MM was investigated in more detail.